Maneuver on CR May Not Pacify Obamacare Critics

Eric Cantor
National Journal
Billy House
Sept. 9, 2013, 5:30 p.m.

House Re­pub­lic­an lead­ers plan to pro­ceed with a vote Thursday on a stop­gap spend­ing bill to keep the gov­ern­ment op­er­at­ing bey­ond Sept. 30, and they plan to in­clude a rare pro­ced­ur­al man­euver to force the Sen­ate to vote on de­fund­ing Pres­id­ent Obama’s health care law.

The strategy be­ing put for­ward by Ma­jor­ity Lead­er Eric Can­tor, R-Va., is in­ten­ded to sat­is­fy con­ser­vat­ives who want to de­rail the Pa­tient Pro­tec­tion and Af­ford­able Care Act. Some have called for Re­pub­lic­ans to use their ma­jor­ity in the House to block spend­ing bills, in­clud­ing so-called con­tinu­ing res­ol­u­tions, as lever­age even if that might lead to a gov­ern­ment shut­down.

Eighty-five House Re­pub­lic­ans have signed a let­ter cir­cu­lated by Rep. Mark Mead­ows, R-N.C., that calls for Can­tor and Speak­er John Boehner to “af­firm­at­ively de­fund the im­ple­ment­a­tion and en­force­ment of Obama­care” in any ap­pro­pri­ations bills. Oth­er con­ser­vat­ives, such as Sens. Ted Cruz, R-Texas, and Mike Lee, R-Utah, have been mak­ing sim­il­ar de­mands.

But it does not ap­pear likely that all of the con­ser­vat­ives will be sat­is­fied by Can­tor’s strategy — which would not ac­tu­ally force law­makers in­to a stark choice of either de­fund­ing the health care over­haul or shut­ting down gov­ern­ment.

Rep. Tim Huel­skamp, R-Kan., who signed Mead­ows’s let­ter, pre­dicted Monday that there would be at least 20 votes against the rule to al­low the House to pro­ceed with such a strategy for the con­tinu­ing res­ol­u­tion. He also said it il­lus­trates that, for some in the House GOP ranks, “you really aren’t op­posed to Obama­care; you just want to say you are.”

Pas­sage of a CR to keep the gov­ern­ment fun­ded is among the key is­sues that law­makers need to ac­com­plish this month, be­cause the House and Sen­ate have not yet agreed on an­nu­al spend­ing bills for the new fisc­al year, which be­gins Oct. 1. House Ap­pro­pri­ations Com­mit­tee Chair­man Har­old Ro­gers, R-Ky., said Monday that he hopes and ex­pects the stop­gap spend­ing bill to be brought to the floor for a vote Thursday. He said it would keep gov­ern­ment run­ning through mid-Decem­ber, giv­ing law­makers more time to ne­go­ti­ate a longer-term spend­ing pack­age.

House GOP aides say top lead­ers also want to make sure gov­ern­ment spend­ing is kept at cur­rent levels — levels that in­clude so-called se­quest­ra­tion cuts to agency budgets.

The Demo­crat­ic-led Sen­ate Ap­pro­pri­ations Com­mit­tee has been writ­ing up that cham­ber’s spend­ing bills to a topline level of $1,058 tril­lion for the new fisc­al year, on the as­sump­tion that Con­gress will re­peal se­quest­ra­tion. But the GOP-led House’s CR fund­ing would be set at a post-se­quester an­nu­al level of $988 bil­lion.

The plan for the CR is to be form­ally an­nounced to mem­bers at the House Re­pub­lic­an Con­fer­ence meet­ing Tues­day.

It calls for the House to sim­ul­tan­eously vote on both the con­tinu­ing res­ol­u­tion for gov­ern­ment spend­ing and a con­cur­rent res­ol­u­tion that would amend the spend­ing bill to in­clude lan­guage on de­fund­ing the health care law. If both pass, the House would then send the de­fund­ing lan­guage to the Sen­ate, ac­cord­ing to a lead­er­ship aide who is fa­mil­i­ar with the plan. The rule for the pack­age would re­quire that the con­tinu­ing res­ol­u­tion it­self can­not be trans­mit­ted to the Sen­ate un­til the up­per cham­ber has con­sidered the de­fund­ing lan­guage.

What We're Following See More »
GERMAN MINISTER SAYS U.S. WON’T COMPROMISE
U.S.-EU Trade Deal a Dead Letter for Now
1 hours ago
THE LATEST

Sigmar Gabriel, the German economic minister, said there's no chance of the Transatlantic Trade and Investment Partnership being agreed upon before the U.S. elections this fall. Gabriel said the United States "had effectively ended talks" on the free trade deal with the European Union "because Washington had not wanted to compromise with its European counterparts."

Source:
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
1 hours ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
1 hours ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

INFLUENCED BY NUKES, POLLUTION
Scientists Declare Dawn of Anthropocene Epoch
4 hours ago
WHY WE CARE

"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."

Source:
EPI-PEN PRICES
House Committee Investigating Mylan
4 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×